HER2 + breast cancer is characterised by HER2 amplification and the low expression of luminal and basal clusters [2, 3] whilst TNBC is characterised by tumours that lack the expression of ER and PR, the absence of HER2 overexpression, and high expression of Ki-67 [2]. This evidence concerns the gene MKI67 and breast cancer.